Recordati
Established in 1926 , Recordati is an international pharmaceutical group with more than 4000 employees worldwide . It is dedicated to the research , development , manufacturing , and marketing of pharmaceutical products , with a particular specialism in pharmaceuticals for cardiovascular , urological and rare diseases disorders . Headquartered in Milan , Italy , the business has a strong global presence , with operations throughout Europe , the US , Canada , Mexico , Japan , and Australia , to name just a few !
Manufacturing Today sat down with Roberto Teruzzi , Executive Vice President of Group Industrial Operations , to discuss the company ’ s growth through acquisitions and how it has navigated various challenges over the last few years . Roberto is joined by Fernando Catrambone , Pharmaceutical Chemicals Senior Director , and Jonathan Humphreys , Manufacturing , Science and Technology ( MSAT ) Director .
With more than 25 years of scientific experience , Fernando is extremely keen on continuous education and emphasizes his passion for research and development within the company . His day-to-day role is to ensure the Chemical Division provides high quality products and services to the wider group and to external customers . Jonathan , however , joined Recordati through the acquisition of EUSA Pharma ( EUSA ), a UKbased biopharmaceutical company focused on rare oncology diseases . Having recently completed the acquisition process ( at the end of
manufacturing-today . com 159